Categories AlphaGraphs, Earnings, Health Care

Johnson & Johnson beats in Q2; raises FY guidance

Johnson & Johnson (NYSE: JNJ) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The pharmaceutical giant reported Q2 sales of $23.3 billion, up 27% year-over-year and higher than the Wall Street projection. Net income of $2.48 per share was also above the target that analysts had anticipated.

JNJ shares were trading flat immediately following the announcement. The stock has gained 7.6% since the beginning of this year.

 johnson & Johnson Q2 2021 earnings

Looking forward to listening to management/analyst comments on the results? Stay tuned here for Johnson & Johnson Q2 earnings call transcript

Prior performance

  • Johnson & Johnson Q4 2020 earnings
  • Johnson & Johnson Q3 2020 earnings
  • Johnson and Johnson reports Q2 2020 earnings results

Most Popular

Kroger (KR) looks set to start 2023 with new vigor. Is the stock a buy?

The retail environment has witnessed many changes in customers’ shopping behavior lately, especially after the COVID outbreak. With inflation putting pressure on personal finances, there appears to be a new

Dollar General (DG): Five takeaways from the discount store’s Q3 earnings report

Shares of Dollar General Corporation (NYSE: DG) were up over 2% on Friday, a day after the company delivered mixed results for the third quarter of 2022 and lowered its

Salesforce stock hit by weak guidance, co-CEO’s exit. What next?

For technology stocks, 2022 has been a challenging year, with companies losing significant market value amid prolonged stock selloff. In that respect, Salesforce, Inc. (NYSE: CRM) is among the worst-affected

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top